Innate lymphoid cells and innate-like T cells in cancer — at the crossroads of innate and adaptive immunity

No abstract is available for this paper.

• Publication year

  2023

• Venue

  Nature Reviews. Cancer

• Publication date

  2023-04-20

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/s41568-023-00562-wPMID 37081117
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• γδ T cells are effectors of immunotherapy in cancers with HLA class I defects

  2023cited by this paper
• Checkpoint Inhibitors Modulate Plasticity of Innate Lymphoid Cells in Peripheral Blood of Patients With Hepatocellular Carcinoma

  2022cited by this paper
• Cytotoxic granzyme C–expressing ILC1s contribute to antitumor immunity and neonatal autoimmunity

  2022cited by this paper
• A circulating subset of iNKT cells mediates antitumor and antiviral immunity

  2022cited by this paper
• Phosphoantigen-stimulated γδ T cells suppress natural killer cell-responses to missing-self.

  2022cited by this paper
• Decade-long leukaemia remissions with persistence of CD4+ CAR T cells

  2022cited by this paper
• Cytotoxic innate lymphoid cells sense cancer cell-expressed interleukin-15 to suppress human and murine malignancies

  2022cited by this paper
• Antitumor immunity induced by antibody-based natural killer cell engager therapeutics armed with not-alpha IL-2 variant

  2022cited by this paper
• A RORγt+ cell instructs gut microbiota-specific Treg cell differentiation

  2022cited by this paper
• Immunogenic cell stress and death

  2022cited by this paper
• Novel antigen-presenting cell imparts Treg-dependent tolerance to gut microbiota

  2022cited by this paper
• A local human Vδ1 T cell population is associated with survival in nonsmall-cell lung cancer

  2022cited by this paper
• Trained ILC3 responses promote intestinal defense

  2022cited by this paper
• Human ILC3 Exert TRAIL-Mediated Cytotoxicity Towards Cancer Cells

  2022cited by this paper
• Innate lymphoid cells and cancer

  2022cited by this paper
• Harnessing natural killer cells for cancer immunotherapy: dispatching the first responders

  2022cited by this paper
• Waves of layered immunity over innate lymphoid cells

  2022cited by this paper
• Lymphatic migration of unconventional T cells promotes site-specific immunity in distinct lymph nodes.

  2022cited by this paper
• Natural killer cells in antitumour adoptive cell immunotherapy

  2022cited by this paper
• Engineering Human MAIT Cells with Chimeric Antigen Receptors for Cancer Immunotherapy

  2022cited by this paper
• γδ T, NKT, and MAIT Cells During Evolution: Redundancy or Specialized Functions?

  2022cited by this paper
• Emerging Paradigms in Type 2 Immunity.

  2022cited by this paper
• Heterogeneity of type 2 innate lymphoid cells

  2022cited by this paper
• ILC3s select microbiota-specific regulatory T cells to establish tolerance in the gut

  2022cited by this paper
• Early-life imprinting of unconventional T cells and tissue homeostasis

  2021cited by this paper
• Blockade of the co-inhibitory molecule PD-1 unleashes ILC2-dependent anti-tumor immunity in melanoma

  2021cited by this paper
• A multilayered immune system through the lens of unconventional T cells

  2021cited by this paper
• Activating Mucosal-Associated Invariant T Cells Induces a Broad Antitumor Response

  2021cited by this paper
• Dysregulation of ILC3s unleashes progression and immunotherapy resistance in colon cancer.

  2021cited by this paper
• Tissue-specific transcriptional imprinting and heterogeneity in human innate lymphoid cells revealed by full-length single-cell RNA-sequencing

  2021cited by this paper
• Landscape of innate lymphoid cells in human head and neck cancer reveals divergent NK cell states in the tumor microenvironment

  2021cited by this paper
• IL-33 Enhances IFNγ and TNFα Production by Human MAIT Cells: A New Pro-Th1 Effect of IL-33

  2021cited by this paper
• Interferon-γ: teammate or opponent in the tumour microenvironment?

  2021cited by this paper
• Liver type 1 innate lymphoid cells develop locally via an interferon-γ–dependent loop

  2021cited by this paper
• The tumour microenvironment shapes innate lymphoid cells in patients with hepatocellular carcinoma

  2021cited by this paper
• Circulating mucosal-associated invariant T cells identify patients responding to anti-PD-1 therapy

  2021cited by this paper
• Human MAIT cells are devoid of alloreactive potential: prompting their use as universal cells for adoptive immune therapy

  2021cited by this paper
• Systemic immunity in cancer

  2021cited by this paper
• The Next Decade of Immune Checkpoint Therapy.

  2021cited by this paper
• Group‐2 Innate Lymphoid Cells Promote HCC Progression Through CXCL2‐Neutrophil‐Induced Immunosuppression

  2021cited by this paper
• Interleukins in cancer: from biology to therapy

  2021cited by this paper
• Adoptive Transfer of Autologous Invariant Natural Killer T Cells as Immunotherapy for Advanced Hepatocellular Carcinoma: A Phase I Clinical Trial

  2021cited by this paper
• Cutaneous Squamous Cell Carcinoma Development is Associated with a Temporal Infiltration of ILC1 and NK Cells with Immune Dysfunctions.

  2021cited by this paper
• Differential controls of MAIT cell effector polarization by mTORC1/mTORC2 via integrating cytokine and costimulatory signals

  2021cited by this paper
• Expansion of donor-unrestricted MAIT cells with enhanced cytolytic function suitable for TCR redirection

  2021cited by this paper
• Ligand recognition by the γδ TCR and discrimination between homeostasis and stress conditions

  2020cited by this paper
• Gamma-Delta CAR-T Cells Show CAR-Directed and Independent Activity Against Leukemia

  2020cited by this paper
• NK Cell Development in Times of Innate Lymphoid Cell Diversity

  2020cited by this paper
• Thymic development of unconventional T cells: how NKT cells, MAIT cells and γδ T cells emerge

  2020cited by this paper
• ILC2-driven innate immune checkpoint mechanism antagonizes NK cell antimetastatic function in the lung

  2020cited by this paper
• Circulating mucosal associated invariant T cells identify patients responding to anti-PD1 therapy

  2020cited by this paper
• Clonal expansion of innate and adaptive lymphocytes

  2020cited by this paper
• Artificially induced MAIT cells inhibit M. bovis BCG but not M. tuberculosis during in vivo pulmonary infection

  2020cited by this paper
• Human liver CD8+ MAIT cells exert TCR/MR1-independent innate-like cytotoxicity in response to IL-15.

  2020cited by this paper
• Cytokines regulate the antigen-presenting characteristics of human circulating and tissue-resident intestinal ILCs

  2020cited by this paper
• Transdifferentiation of tumor infiltrating innate lymphoid cells during progression of colorectal cancer

  2020cited by this paper
• A guide to cancer immunotherapy: from T cell basic science to clinical practice

  2020cited by this paper
• Exploring the NK cell platform for cancer immunotherapy

  2020cited by this paper
• Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors.

  2020cited by this paper
• Next-generation cell therapies: the emerging role of CAR-NK cells.

  2020cited by this paper
• A trispecific killer engager molecule against CLEC12A effectively induces NK cell mediated killing of AML cells

  2020cited by this paper
• Immune recognition of phosphoantigen‐butyrophilin molecular complexes by γδ T cells

  2020cited by this paper
• Tumor-Infiltrating Natural Killer Cells.

  2020cited by this paper
• Tissue Determinants of Human NK Cell Development, Function, and Residence.

  2020cited by this paper
• Plasticity of innate lymphoid cell subsets

  2020cited by this paper
• Identification of human cytotoxic ILC3s

  2020cited by this paper
• Tissue-Specific Features of Innate Lymphoid Cells.

  2020cited by this paper
• The multifaceted role of TRAIL signaling in cancer and immunity

  2020cited by this paper
• Next-generation cell therapies: the emerging role of CAR-NK cells.

  2020cited by this paper
• Expansion With IL-15 Increases Cytotoxicity of Vγ9Vδ2 T Cells and Is Associated With Higher Levels of Cytotoxic Molecules and T-bet

  2020cited by this paper
• MAIT cells regulate NK cell-mediated tumor immunity

  2020cited by this paper
• Phase II study of α-galactosylceramide-pulsed antigen-presenting cells in patients with advanced or recurrent non-small cell lung cancer

  2020cited by this paper
• NK cells and ILCs in tumor immunotherapy.

  2020cited by this paper
• Inhibitory Receptors and Checkpoints in Human NK Cells, Implications for the Immunotherapy of Cancer

  2020cited by this paper
• A Phase 1 Study of the Combination of MG4101, Ex Vivo-Expanded Allogeneic NK Cells and Rituximab for Relapsed or Refractory Non-Hodgkin Lymphoma

  2020cited by this paper
• MAIT cell-directed therapy of Mycobacterium tuberculosis infection

  2020cited by this paper
• ILC2s amplify PD-1 blockade by activating tissue-specific cancer immunity

  2020cited by this paper
• Activation and In Vivo Evolution of the MAIT Cell Transcriptome in Mice and Humans Reveals Tissue Repair Functionality

  2019cited by this paper
• An innate-like Vδ1+ γδ T cell compartment in the human breast is associated with remission in triple-negative breast cancer

  2019cited by this paper
• Transforming Growth Factor-β Signaling in Immunity and Cancer.

  2019cited by this paper
• Microbial metabolites control the thymic development of mucosal-associated invariant T cells

  2019cited by this paper
• Dendritic cells in cancer immunology and immunotherapy

  2019cited by this paper
• Hide and seek: Plasticity of innate lymphoid cells in cancer.

  2019cited by this paper
• IL23-Producing Human Lung Cancer Cells Promote Tumor Growth via Conversion of Innate Lymphoid Cell 1 (ILC1) into ILC3

  2019cited by this paper
• TCR- or Cytokine-Activated CD8+ Mucosal-Associated Invariant T Cells Are Rapid Polyfunctional Effectors That Can Coordinate Immune Responses.

  2019cited by this paper
• MAIT cells are imprinted by the microbiota in early life and promote tissue repair

  2019cited by this paper
• Oncogenic kinase inhibition limits Batf3-dependent dendritic cell development and antitumor immunity

  2019cited by this paper
• Genome-wide CRISPR-Cas9 Screening Reveals Ubiquitous T cell Cancer Targeting via the monomorphic MHC class I related protein MR1

  2019cited by this paper
• Transcription Factors in the Development and Function of Group 2 Innate Lymphoid Cells

  2019cited by this paper
• Chronically stimulated human MAIT cells are unexpectedly potent IL‐13 producers

  2019cited by this paper
• MAIT cells promote tumor initiation, growth and metastases via tumor MR1.

  2019cited by this paper
• c-Kit-positive ILC2s exhibit an ILC3-like signature that may contribute to IL-17-mediated pathologies

  2019cited by this paper
• γδ T cells: pleiotropic immune effectors with therapeutic potential in cancer

  2019cited by this paper
• Epithelial cell–derived cytokines: more than just signaling the alarm

  2019cited by this paper
• NK cells switch from granzyme B to death receptor–mediated cytotoxicity during serial killing

  2019cited by this paper
• Lymphocyte innateness defined by transcriptional states reflects a balance between proliferation and effector functions

  2019cited by this paper
• Commensal Microbiota Promote Lung Cancer Development via γδ T Cells.

  2019cited by this paper
• Natural Killer Cells as Allogeneic Effectors in Adoptive Cancer Immunotherapy

  2019cited by this paper
• Activated and Exhausted MAIT Cells Foster Disease Progression and Indicate Poor Outcome in Hepatocellular Carcinoma

  2019cited by this paper
• Multifunctional Natural Killer Cell Engagers Targeting NKp46 Trigger Protective Tumor Immunity.

  2019cited by this paper

• Metabolic‐immune interactions in gastric cancer T cells: A single‐cell atlas for prognostic biomarker identification

  2026cites this paper
• Reshaping the colorectal cancer immune microenvironment: insights from single-cell and spatial omics.

  2026cites this paper
• Photoactivatable Nanozyme-Integrated Microneedles Orchestrate a Self-Amplifying Immunogenic Cell Death-STING Signaling Circuit for Tumor Immune Rewiring.

  2026cites this paper
• Radiotherapy disrupts ferroptosis tolerance by reducing DNMT1 levels and uncouples STING silencing in LKB1-deficient lung tumors.

  2026cites this paper
• Advances in delivery technologies-powered cancer vaccines.

  2026cites this paper
• Immunophenotyping of conventional and non-conventional T cell populations by surface staining of peripheral blood mononuclear cells.

  2026cites this paper
• Identification of VEGFB associated with NKT cells in diabetic foot ulcers: Single-cell analysis and machine learning

  2026cites this paper
• Insights into the Biochemical and Immune Mechanisms in Drug-Induced Liver Injury Pathogenesis.

  2026cites this paper
• Modulation of intestinal microbiota and metabolites mediates the improvement of cyclophosphamide-induced immunodeficiency in mice by Monopterus albus slime protein.

  2026cites this paper
• CCL17 in pan-vascular diseases: current research advances

  2026cites this paper
• Innate lymphoid cells as emerging players in cancer immunotherapy

  2026cites this paper
• An on-site cascading vaccine breaks tumor immune evasion and elicits systemic immunity.

  2026cites this paper
• Innate Lymphoid Cells in Pancreatic Ductal Adenocarcinoma: Immune Regulation and Therapeutic Implications.

  2025cites this paper
• Resistance to immunotherapy in non-small cell lung cancer: Unraveling causes, developing effective strategies, and exploring potential breakthroughs.

  2025cites this paper
• Dynamic changes of host immune response during Helicobacter pylori-induced gastric cancer development.

  2025cites this paper
• Engineered NK Exosomes Captured Antigens In Situ for Enhanced Tumor Immunotherapy.

  2025cites this paper
• T-cell receptor dynamics in digestive system cancers: a multi-layer machine learning approach for tumor diagnosis and staging

  2025cites this paper
• Knowledge map of programmed cell death in esophageal cancer: a bibliometric analysis

  2025cites this paper
• From neglect to necessity: the role of innate immunity in cutaneous squamous cell carcinoma therapy

  2025cites this paper
• Decoding innate lymphoid cells and innate-like lymphocytes in asthma: pathways to mechanisms and therapies

  2025cites this paper
• A Systematic Review of Immune Cell Roles in Breast Cancer Immunotherapy

  2025cites this paper
• Spatial mapping of innate lymphoid cells in human lymphoid tissues and lymphoma at single-cell resolution

  2025cites this paper
• A lyophilizable LNP vaccine enables STING-reinforced postoperational adjuvant immunotherapy

  2025cites this paper
• Identification of biomarkers associated with inflammatory response in Parkinson’s disease by bioinformatics and machine learning

  2025cites this paper
• Interleukin-enhanced CAR-engineered immune cells in tumor immunotherapy: current insights and future perspectives.

  2025cites this paper
• Dendritic Cell-Based Cancer Vaccines: The Impact of Modulating Innate Lymphoid Cells on Anti-Tumor Efficacy

  2025influential citation
• Advances in molecular pathology and therapy of non-small cell lung cancer

  2025cites this paper
• Prognostic impact of pan-immune inflammation value in small-cell lung cancer treated with chemoradiotherapy and prophylactic cranial irradiation

  2025cites this paper
• Innate Lymphoid Cells.

  2025cites this paper
• Optogenetic‐Controlled iPSC‐Based Vaccines for Prophylactic and Therapeutic Tumor Suppression in Mice

  2025cites this paper
• Advanced Cancer Immunotherapy via SMARCAL1 Blockade Using a Glucose‐Responsive CRISPR Nanovaccine

  2025cites this paper
• Extracellular Vesicles for Clinical Diagnostics: From Bulk Measurements to Single-Vesicle Analysis

  2025cites this paper
• Interplay between innate-like T-cells and microRNAs in cancer immunity

  2025cites this paper
• SIRPA, BTN3A1, and TDO2 in osteosarcoma: a prognostic triad with therapeutic implications from integrated genomic and pharmacogenomic data

  2025cites this paper
• Sophora flavescens-derived extracellular vesicles loaded with oncolytic vaccinia virus/IR1061 for NIR-II photoacoustic imaging guided multimodal treatment of diffuse large B-cell lymphoma

  2025cites this paper
• Stimulator of interferon genes-targeted positron emission tomography tracks early microbiota-induced tumor immune remodeling and guides immunotherapy.

  2025cites this paper
• Heterogeneity of Innate Immunity

  2025cites this paper
• A Self‐Reinforcing Metabolic Nanojammer for Activating Cascade‐Augmented Cuproptosis‐Driven Immunotherapy

  2025cites this paper
• Innate lymphoid cells in the spotlight: from biomarkers to blueprint for innovative immunotherapy

  2025cites this paper
• Metabolic control of innate-like T cells

  2025cites this paper
• CD103+CD8+ tissue‐resident memory T lymphocytes of melanoma boost anti‐tumour immunity and predict immunotherapy outcomes

  2025cites this paper
• The immune microenvironment of colorectal cancer

  2025cites this paper
• Deep Learning‐Driven Co‐Assembly of Naturally Sourced Compound Nanoparticles for Potentiated Cancer Immunotherapy

  2025cites this paper
• Interleukin 15 and autoimmune disorders: pathophysiology, therapeutic potential, and clinical implications

  2025cites this paper
• Cell encapsulated biomaterials for translational medicine

  2025cites this paper
• Innate immunity in tumour immunoediting and immunosurveillance

  2025influential citation
• IL-1 family members as regulators of lymphoid type-2 immunity in cancer.

  2025cites this paper
• Programmable Nucleic Acid Origami Nanostructures for Immunotherapy

  2025cites this paper
• T cell-intrinsic PRR signaling in immunity and pathology

  2025cites this paper
• Extracellular vesicles in tumor microenvironment modulation and clinical diagnosis.

  2025cites this paper
• Modifying metabolic and immune hallmarks of cancer by a copper complex

  2025cites this paper
• Advanced Polymeric Nanoparticles for Cancer Immunotherapy: Materials Engineering, Immunotherapeutic Mechanism and Clinical Translation

  2025cites this paper
• STING in Cancer Immunoediting: Modeling Tumor-Immune Dynamics Throughout Cancer Development.

  2025cites this paper
• Association between systemic immune-inflammation index and the risk of all-cause, cancer and non-cancer mortality in the general population: results from national health and nutrition examination survey 2005–2018

  2025cites this paper
• The neutrophil-to-lymphocyte ratio and the prevalence of cutaneous melanoma: a retrospective observational study of NHANES statistics spanning 1999 to 2018

  2025cites this paper
• The m6A revolution: transforming tumor immunity and enhancing immunotherapy outcomes

  2025cites this paper
• Helper ILCs in the human hematopoietic system.

  2025cites this paper
• Type 2 innate lymphoid cells are not involved in mouse bladder tumor development

  2024cites this paper
• Unlocking the potential of T‐cell metabolism reprogramming: Advancing single‐cell approaches for precision immunotherapy in tumour immunity

  2024cites this paper
• Alcohol-associated liver cancer

  2024cites this paper
• Implications of innate lymphoid cells in oral diseases.

  2024cites this paper
• Immunocytes interact directly with cancer cells in the tumor microenvironment: one coin with two sides and future perspectives

  2024influential citation
• Distinctive multicellular immunosuppressive hubs confer different intervention strategies for left- and right-sided colon cancers

  2024cites this paper
• Circulating subpopulations of non-cytotoxic ILCs in diffuse large B-cell lymphoma

  2024cites this paper
• Innate-like T cells in liver disease.

  2024cites this paper
• Rejuvenation Strategy for Inducing and Enhancing Autoimmune Response to Eliminate Senescent Cells

  2024cites this paper
• Innate immune cells in tumor microenvironment: A new frontier in cancer immunotherapy

  2024cites this paper
• Spatial single-cell profiling and neighbourhood analysis reveal the determinants of immune architecture connected to checkpoint inhibitor therapy outcome in hepatocellular carcinoma

  2024cites this paper
• Cancer-induced systemic pre-conditioning of distant organs: building a niche for metastatic cells

  2024cites this paper
• Innate lymphoid cells in the brain: Focus on ischemic stroke.

  2024cites this paper
• Comprehensive single-cell and bulk transcriptomic analyses to develop an NK cell-derived gene signature for prognostic assessment and precision medicine in breast cancer

  2024cites this paper
• Convergent inducers and effectors of T cell paralysis in the tumour microenvironment

  2024cites this paper
• Protecting Against Postsurgery Oral Cancer Recurrence with an Implantable Hydrogel Vaccine for In Situ Photoimmunotherapy

  2024cites this paper
• Exogenous IL-33 promotes tumor immunity via macroscopic regulation of ILC2s

  2024cites this paper
• Metabolic Reprogramming of Immune Cells in the Tumor Microenvironment

  2024cites this paper
• Mechanism and Therapeutic Targets of Circulating Immune Cells in Diabetic Retinopathy.

  2024cites this paper
• Integrative mapping of human CD8+ T cells in inflammation and cancer

  2024cites this paper
• Development of anti-cancer drugs for tumor-associated macrophages: a comprehensive review and mechanistic insights

  2024cites this paper
• Insight into the Interaction Mechanism of Pseudorabies Virus Infection

  2024cites this paper
• Engineering the physical characteristics of biomaterials for innate immune-mediated cancer immunotherapy.

  2024cites this paper
• Prognostic Significance of Preoperative NLR or PLR and PASS Score Combinations in Pheochromocytoma and Paraganglioma

  2024cites this paper
• IL-15 in T-Cell Responses and Immunopathogenesis

  2024cites this paper
• Advances in understanding immune homeostasis in latent tuberculosis infection.

  2024cites this paper
• Immunomodulation of wound healing leading to efferocytosis

  2024cites this paper
• High-dimensional in situ proteomics imaging to assess γδ T cells in spatial biology.

  2024cites this paper
• zDHHC20-driven S-palmitoylation of CD80 is required for its costimulatory function

  2024cites this paper
• Adoptive cell immunotherapy for breast cancer: harnessing the power of immune cells.

  2023cites this paper
• Immunoediting of KEAP1-NRF2 mutant tumours is required to circumvent NRF2-mediated immune surveillance

  2023cites this paper
• An RNA-Scaffold Protein Subunit Vaccine for Nasal Immunization

  2023cites this paper
• Evasion of host defense by Brucella

  2023cites this paper
• Natural Killer T Cell Diversity and Immunotherapy

  2023cites this paper
• Chimeric Antigen Receptor T Cell Therapy in Acute Myeloid Leukemia: Trials and Tribulations

  2023cites this paper
• Exploiting innate immunity for cancer immunotherapy

  2023cites this paper
• Nuclear‐Targeted Nanostrategy Regulates Spatiotemporal Communication for Dual Antitumor Immunity

  2023cites this paper